Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

BayesMendel: an R environment for Mendelian risk prediction.

Chen S, Wang W, Broman KW, Katki HA, Parmigiani G.

Stat Appl Genet Mol Biol. 2004;3:Article21. Epub 2004 Sep 17.

4.

Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.

Mazzola E, Blackford A, Parmigiani G, Biswas S.

Cancer Inform. 2015 May 10;14(Suppl 2):147-57. doi: 10.4137/CIN.S17292. eCollection 2015. Review.

5.

Prediction of germline mutations and cancer risk in the Lynch syndrome.

Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K, Watson P, Gruber SB, Euhus D, Kinzler KW, Jass J, Gallinger S, Lindor NM, Casey G, Ellis N, Giardiello FM, Offit K, Parmigiani G; Colon Cancer Family Registry..

JAMA. 2006 Sep 27;296(12):1479-87.

6.

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E.

J Natl Cancer Inst. 1997 Feb 5;89(3):227-38.

PMID:
9017003
7.
8.

Simple and complex genetics of colorectal cancer susceptibility.

Baglioni S, Genuardi M.

Am J Med Genet C Semin Med Genet. 2004 Aug 15;129C(1):35-43. Review.

PMID:
15264271
9.

PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?

Mester JL, Moore RA, Eng C.

Oncologist. 2013;18(10):1083-90. doi: 10.1634/theoncologist.2013-0174. Epub 2013 Sep 13.

10.

BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.

Capalbo C, Ricevuto E, Vestri A, Ristori E, Sidoni T, Buffone O, Adamo B, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G.

Ann Oncol. 2006 Jun;17 Suppl 7:vii34-40.

PMID:
16760289
11.

Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.

Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, Mutch DG, Berchuck A, Karlan BY, Herzog TJ; Society of Gynecologic Oncologists Education Committee..

Gynecol Oncol. 2007 Nov;107(2):159-62.

PMID:
17950381
12.

Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes.

Cruz-Correa M, Diaz-Algorri Y, Mendez V, Vazquez PJ, Lozada ME, Freyre K, Lathroum L, Gonzalez-Pons M, Hernandez-Marrero J, Giardiello F, Rodriguez-Quilichini S.

Fam Cancer. 2013 Sep;12(3):555-62. doi: 10.1007/s10689-013-9617-z.

13.

Genetics of hereditary colon cancer.

de la Chapelle A, Peltomäki P.

Annu Rev Genet. 1995;29:329-48. Review.

PMID:
8825478
14.

Hereditary risk of women's cancers.

Frank TS, Critchfield GC.

Best Pract Res Clin Obstet Gynaecol. 2002 Oct;16(5):703-13. Review.

PMID:
12475549
15.

Genetic testing by cancer site: stomach.

Chun N, Ford JM.

Cancer J. 2012 Jul-Aug;18(4):355-63. doi: 10.1097/PPO.0b013e31826246dc. Review.

PMID:
22846738
16.

Molecular and phenotypic markers of hamartomatous polyposis syndromes in the gastrointestinal tract.

Entius MM, Westerman AM, van Velthuysen ML, Wilson JH, Hamilton SR, Giardiello FM, Offerhaus GJ.

Hepatogastroenterology. 1999 Mar-Apr;46(26):661-6. Review.

PMID:
10370593
17.

Hereditary pancreatic cancer.

Lynch HT, Brand RE, Deters CA, Shaw TG, Lynch JF.

Pancreatology. 2001;1(5):466-71. Review.

PMID:
12120226
18.

Genetic counseling in hereditary non-polyposis colorectal cancer.

Heouaine A, Mareni C, Varesco L, Genuardi M, Neri G.

Tumori. 1996 Mar-Apr;82(2):136-42. Review.

PMID:
8644375
19.

Hereditary cancer in adults.

Lynch HT, Fusaro RM, Lynch J.

Cancer Detect Prev. 1995;19(3):219-33. Review.

PMID:
7750110
20.

Early-onset colorectal cancer: a sporadic or inherited disease?

Stigliano V, Sanchez-Mete L, Martayan A, Anti M.

World J Gastroenterol. 2014 Sep 21;20(35):12420-30. doi: 10.3748/wjg.v20.i35.12420. Review.

Supplemental Content

Support Center